Citations

Clear

142 citation(s) found for "Hsieh, TC".

Improving Calibration of Photon Counting Detector CT Using Redundant Sampling
Hsieh, Scott S. , Day, James , Deng, Xiaoyuan , Bazalova‐Carter, Magdalena

Mayo Clinic

2025 IEEE Nuclear Science Symposium (NSS), Medical Imaging Conference (MIC) and Room Temperature Semiconductor Detector Conferen | December 18, 2025 | Volume: No volume available | Issue: No issue available | Pages: 1-1

10.1109/nss/mic/rtsd57106.2025.11286727 Get It

0.05% Chlorhexidine gluconate is not associated with infection in antibiotic impregnated inflatable penile prosthesis surgery: results from a large multi-institutional collaborative
Ivan, Samuel , Chawareb, Elia Abou , Hammad, Muhammed, Lesgart, Michael , Baird, Bryce , Bajic, Petar , Barham, David W. , Bernie, Helen Levey, Chung, Paul, Cowan, Ketch , Dominick, Zayda, Good, J , Hsieh, Michael H. , Im, Brian H. , Kadakia, Y , Kohler, T, Lentz, Aaron , Mass-Lindenbaum, Marcelo , Morey, Allen F, Perito, Paul , Sadeghi‐Nejad, Hossein , Schammel, Joshua , Shridharani, Anand, Sarantos, Nicklas, Suarez‐Sarmiento, Alfredo, Warner, J Nicholas, Welliver, Charles E, Ziegelmann, M, Yafi, Faysal A, Gross, Martin , Simhan, Jay, Hammad, Muhammed , Ivan, Samuel J , Abou Chawareb, Elia , Helo, Sevann , Hammad, Muhammed A M , Bernie, Helen L. , Bole, Raevti , Kadakia, Yash , Morey, Allen F. , Nguyen, Vi , Pereira, Thairo Alves , Sarantos, Nicklas , Welliver, Charles , Ziegelmann, M, Yafi, Faysal A. , Simhan, Jay

Mayo Clinic

The Journal of Sexual Medicine | December 12, 2025 | Volume: 23 | Issue: 1 | Pages: No page available

10.1093/jsxmed/qdaf368 | PMID 41489194 Get It

Abstract Background 0.05% Chlorhexidine gluconate (CHG) is now commonly used as an antiseptic irrigation for inflatable penile prosthesis (IPP) surgery. Limited in vitro data suggest compatibility of 0.05% CHG with antibiotic impregnated IPP devices; however, very little clinical research exists to guide use of 0.05% CHG in this population. Aim Assess the relationship of 0.05% CHG and antibiotic impregnated IPP infection in a large multi-institutional cohort. Methods We retrospectively reviewed a multi-institutional cohort of patients who underwent antibiotic impregnated IPP implantation. We identified cases using intraoperative 0.05% CHG and an equal number of consecutive control cases without 0.05% CHG use from each center for comparison. The primary outcome was IPP infection requiring explantation. Patient demographics and surgical variables were analyzed using chi-square tests and multivariable logistic regression to identify variables associated with infection. Outcomes The primary outcome was IPP infection requiring device explanation. Results Among 14 participating institutions, 761 cases using an antibiotic impregnated IPP were analyzed. Of these, 348 (45.7%) had 0.05% CHG used during the case. Median follow-up was 4 months (interquartile range 1-12) for the 0.05% CHG group and 8 months (interquartile range 2-21) for the control group. Intraoperative 0.05% CHG utilization was not associated with antibiotic impregnated IPP infection rate (1.9% vs. 2.0%, P = .9). On multivariable analysis, prior IPP infection (OR 6.32, 95% CI 1.32-30.2, P = .021) and prior priapism (OR 10.01, 95% CI 1.18-89.7, P = .039) were associated with increased infection risk. Clinical implications The use of 0.05% CHG irrigation with antibiotic impregnated IPPs was associated with similar infection rates compared to antibiotic irrigation. Strengths and limitations Limitations include the use of a historical comparator cohort which may introduce unknown confounders, practice variation between multiple sites, shorter follow-up in the 0.05% CHG cohort, and the low incidence of IPP infection which may limit statistical power despite a large sample. The major strengths include the large, multi-institutional cohort, and the use of consecutive patients to minimize selection bias. Conclusion 0.05% CHG utilization was not associated with infection rates in antibiotic impregnated IPPs.
(389) Multicenter Evaluation on the Use of Down-Sized Cylinders Penile Prosthesis: When to Go Narrow?
Lee, J, Swerdloff, Daniel , Sadeghi‐Nejad, Hossein , Pearce, Ian , Lentz, A, Gross, Kelli, Hotaling, James M. , Sempels, Maxime, Park, S Hun, Renterghem, Katrien Van, Hatzichristodoulou, G, Levy, Jason A. , Andrianne, Robert, Hsieh, Tung‐Chin , Modgil, Vaibhav , Jones, Adam , Warner, J, Ziegelmann, M., Suarez-Sarmiento, A, Perito, P, Simhan, Jay , Gross, M, Yafi, Faysal A. , Barham, David , Lee, J, Chawareb, Elia Abou , Hammad, M, Miller, Jake A. , Azad, Babak Kazemzadeh , Osmonov, D, Burnett, Arthur L. “Bud” , Lentz, A, Hatzichristodoulou, Georgios , Levy, J, Jones, James M. , Suarez‐Sarmiento, Alfredo, Gross, Martin

Mayo Clinic

The Journal of Sexual Medicine | December 9, 2025 | Volume: 22 | Issue: Supplement_4 | Pages: No page available

10.1093/jsxmed/qdaf320.383 Get It

Abstract Introduction Down-sized inflatable penile prosthesis (IPP) cylinders are useful in cases with substantial penile fibrosis such as history of priapism or prior infection. Although down-sized IPP cylinders have a clear role in fibrotic corpora, their role in primary implant cases is unclear. Objective To identify factors associated with the use of down-sized cylinders in men undergoing primary IPP placement. Methods We conducted a retrospective analysis of 4,389 patients undergoing primary IPP placement from our multicenter database. Patients were categorized by down-sized (AMS 700 CXR, Coloplast NB) vs. standard sized cylinders (AMS 700 CX, AMS 700 LGX, Coloplast Titan). We collected demographic, intraoperative, and postoperative data. A multivariable analysis was performed to identify factors associated with use of down-sized cylinders Results A total of 4,389 men undergoing primary inflatable penile prosthesis (IPP) placement were included in the study, with a mean age of 62.3 ± 10.3 years. Among them, 1,485 (34%) had diabetes and 2,131 (49%) had hypertension. A total of 406 down-sized cylinders and 3,983 standard cylinders were implanted. Non-infectious complications occurred more frequently with the use of down-sized cylinders (odds ratio [OR] = 2.0, p < 0.001). Specifically, non-infectious complications were reported in 44 out of 185 men (23.8%) with down-sized cylinders, compared to 192 out of 2,727 men (10.9%) with standard cylinders. Cylinder complications constituted 13.9% and 13.0% of the non-infectious complications in the down-sized and standard cylinder groups, respectively. Conclusions The rate of cylinder-related complications were similar between the down-sized cylinder and standard cylinder groups. Urologists should be prepared to place down-sized cylinders during IPP placement in diabetic men and in men requiring serial dilation due to fibrosis. Disclosure Any of the authors act as a consultant, employee or shareholder of an industry for: Intuitive Surgical, Fidelis, Urofill, Boston Scientific, Coloplast, Cynosure, Antares Pharma, Clarus Pharmaceuticals, Acerus Pharma; Endo Pharma.
(344) Infection Rates With Intraoperative 0.05% Chlorhexidine Gluconate Irrigation in Minocycline and Rifampin Impregnated Penile Prostheses: Initial Results From a Large Multi-Institutional Cohort
Chawareb, E Abou, Ivan, S, Hammad, M, Lesgart, M, Baird, B, Bajic, P, Barham, D, Bernie, H, Bole, R, Chung, P, Cowan, K, Dominick, Z, Good, J, Helo, S, Hsieh, M, Im, B, Kadakia, Y, Kohler, T, Lentz, A, Mass-Lindenbaum, M, Morey, A, Nguyen, V, Pereira, T, Perito, P, Sadeghi-Nejad, H, Schammel, J, Shridharani, A, Sarantos, N, Suarez-Sarmiento, A, Warner, J, Welliver, C, Ziegelmann, M, Yafi, F, Gross, M, Simhan, J, Chawareb, E Abou, Ivan, S, Hammad, M, Lesgart, M, Baird, B, Bajic, P, Barham, D, Bernie, H, Bole, R, Chung, P, Cowan, K, Dominick, Z, Good, J, Helo, S, Hsieh, M, Im, B, Kadakia, Y, Kohler, T, Lentz, A, Mass-Lindenbaum, M, Morey, A, Nguyen, V, Pereira, T, Perito, P, Sadeghi-Nejad, H, Schammel, J, Shridharani, A, Sarantos, N, Suarez-Sarmiento, A, Warner, J, Welliver, C, Ziegelmann, M, Yafi, F, Gross, M, Simhan, J

Mayo Clinic

The Journal of Sexual Medicine | December 9, 2025 | Volume: 22 | Issue: Supplement_4 | Pages: No page available

10.1093/jsxmed/qdaf320.339 Get It

Abstract Introduction 0.05% Chlorhexidine Gluconate (CHG) has gained popularity as an irrigant for inflatable penile prosthesis (IPP). In vitro data has explored interactions between CHG and minocycline/rifampin impregnated (M/R) IPP surfaces Objective We aimed to assess clinical infection rates between intraoperative CHG use and M/R impregnated IPPs in a large multi-institutional cohort. Methods We conducted a retrospective analysis of 1,604 patients who underwent IPP implantation across 12 referral centers. Data collection spanned from January 1, 2017 to March 1, 2024. Each surgeon contributed patients who underwent IPP implantation with the use of CHG as an irrigant and an equal number of consecutive control patients where CHG was not used. The primary outcome was explant for postoperative infection. Patient demographics were compared using chi squared testing and logistic regression analysis was performed to assess factors associated with infection. Results M/R impregnated devices accounted for 695 cases. The incidence of infection with intraoperative CHG use was 1.7% (5/289) and was not significantly different from the 2.5% (10/406) infection rate in those without CHG (p=0.429). Patients with infection had a higher prevalence of hypertension and history of priapism (Table 1). On logistic regression analysis, only a history of priapism was significantly associated with an increased odds of infection (OR 11.47, 95%CI 2.25-58.40, p=0.003). Intraoperative CHG use was not associated with postoperative infection (OR 0.69, 95%CI 0.2-2.06. p=0.514). Conclusions In a large multi-institutional cohort, there was no difference in infection rate for patients with or without intraoperative CHG use, consistent with prior in vitro findings. Disclosure Any of the authors act as a consultant, employee or shareholder of an industry for: Intuitive Surgical, Fidelis, Urofill, Boston Scientific, Coloplast, Cynosure, Antares Pharma, Clarus Pharmaceuticals, Acerus Pharma; Endo Pharma.
(064) Microbial Patterns of Inflatable Penile Prosthesis Infections With Intraoperative 0.05% Chlorhexidine Gluconate: Findings From a Large Multi-Institutional Cohort
Ivan, S, Hammad, M, Chawareb, E Abou, Lesgart, M, Baird, B, Bajic, P, Barham, D, Bernie, H, Bole, R, Chung, P, Cowan, K, Dominick, Z, Good, J, Helo, S, Hsieh, M, Im, B, Kadakia, Y, Kohler, T, Lentz, A, Mass-Lindenbaum, M, Morey, A, Nguyen, V, Pereira, T, Perito, P, Sadeghi-Nejad, H, Schammel, J, Shridharani, A, Sarantos, N, Jr., A Suarez-Sarmiento, Warner, N, Welliver, C, Ziegelmann, M, Yafi, F, Gross, M, Simhan, J, collaborators, on behalf of the Prosthetic Urology Multi-institutional Partnership (PUMP), Ivan, S, Hammad, M, Chawareb, E Abou, Lesgart, M, Baird, B, Bajic, P, Barham, D, Bernie, H, Bole, R, Chung, P, Cowan, K, Dominick, Z, Good, J, Helo, S, Hsieh, M, Im, B, Kadakia, Y, Kohler, T, Lentz, A, Mass-Lindenbaum, M, Morey, A, Nguyen, V, Pereira, T, Perito, P, Sadeghi-Nejad, H, Schammel, J, Shridharani, A, Sarantos, N, Jr., A Suarez-Sarmiento, Warner, N, Welliver, C, Ziegelmann, M, Yafi, F, Gross, M, Simhan, J, collaborators, on behalf of the Prosthetic Urology Multi-institutional Partnership (PUMP)

Mayo Clinic

The Journal of Sexual Medicine | December 9, 2025 | Volume: 22 | Issue: Supplement_4 | Pages: No page available

10.1093/jsxmed/qdaf320.064 Get It

Abstract Introduction 0.05% Chlorhexidine Gluconate (CHG) has increasingly been used as an irrigant for inflatable penile prosthesis (IPP) surgery. Recent in vitro data shows mixed results regarding efficacy, but clinical data is lacking. Objective To explore the cultured organisms and infection characteristics of IPP infections with and without intraoperative CHG use from a large multi-institutional cohort. Methods We queried a retrospective multi-institutional database of patients who underwent IPP placement for cases resulting in IPP Infection. We stratified cases by intraoperative use of CHG as an irrigant or dip. We compared patient and infection characteristics using chi squared tests and independent t-tests. Culture data from IPP explant was reviewed for descriptive analysis. Results We identified 70 IPP infections, 43 with intraoperative CHG use. Patient demographics were similar between infection cohorts. (Table 1). Median time to infection was similar, 46.5 days in the CHG cohort and 34 days in the non-CHG cohort (p=0.518). Culture data were available for 57 (81.4%) patients. For CHG IPP infections, 8 had Escherichia coli cultured at time of explant and 6 grew methicillin sensitive Staphylococcus aureus. For non-CHG IPP infections, Staphylococcus epidermidis (4) and Pseudomonas aeruginosa (3) were the most common cultured organisms. A total of nine unique organisms were cultured for both CHG and non-CHG infections. Negative growth cultures were recorded for 2 patients in both the CHG and non-CHG infection groups. (Figure 1) Conclusions In a large, multi-institutional cohort, IPP infections after intraoperative CHG use were associated with a variety of cultured organisms, most commonly Escherichia coli and Methicillin sensitive Staphylococcus aureus. Disclosure Any of the authors act as a consultant, employee or shareholder of an industry for: Coloplast: Advisory board, speaker; Endo: Advisory board; Haleon: Advisory board; Halozyme: Advisory board, speaker; Masimo: Intellectual property; Softwave: Advisory board; Sprout: Consultant; Vertica: Research investigator; Xialla: Advisory board.
Surgical Treatment of Brain Tumor-Related Epilepsy: Current and Emerging Strategies
Khalili, Bobak F. , Chojnacki, Michael R., Dixit, Karan , Gururangan, Kapil , Rosenow, Joshua M. , Hsieh, Jason , Magill, Stephen T. , Tate, Matthew C. , Lukas, Rimas V. , Templer, Jessica W. , Rosenow, Joshua M , Magill, Stephen T , Lukas, Rimas V , Templer, Jessica W , Horbinski, Craig

Mayo Clinic

Cancers | November 3, 2025 | Volume: 17 | Issue: 21 | Pages: 3539

10.3390/cancers17213539 | PMID 41228332 Get It

Brain tumor-related epilepsy (BTRE) is a common and debilitating symptom of central nervous system (CNS) tumors. The epileptogenic zone, defined as cortex responsible for seizure generation, is located at the peritumoral region for most tumors, and lower-grade intrinsic brain tumors have the highest seizure incidence. Surgery is often the most effective treatment for the reduction in seizures in BTRE. However, surgical decisions have historically often been made exclusively for oncologic reasons, with less emphasis on seizure control. Surgical approaches for all tumor types are reviewed, highlighting relevant risk factors. Adjunctive tools during surgery, such as intraoperative electrocorticography (ECoG), may help identify and remove surrounding brain areas which are epileptogenic. Minimally invasive surgery is also gaining traction, given its utility in treating seizures deep-seated tumors. This review explores epileptogenic brain tumors, surgery for BTRE, and emerging strategies to better achieve seizure control.
(010) UNVEILING THE IMPACT OF BODY MASS INDEX ON OVERALL OUTCOMES OF INFLATABLE PENILE PROSTHESIS PLACEMENT: INSIGHTS FROM AN INTERNATIONAL, MULTI-CENTER INVESTIGATION
Hammad, MAM, Gross, MS, Andrianne, Robert, Burnett, AL, Gross, Kelli, Hatzichristodoulou, G, Lentz, A, Modgil, Vaibhav , Perito, P, Hotaling, JM, Park, SH, Pearce, Ian , Sadeghi‐Nejad, Hossein , Sempels, Maxime, Suarez-Sarmiento, A, Renterghem, Katrien Van, Warner, J, Ziegelmann, Matthew , Hsieh, TC, Karthikeyan, Hridhay, Simhan, Jay , Yafi, FA, collaborators, on behalf of the PUMP (Prosthetic Urology Multi-institutional Partnership), Barham, DW, Hammad, Muhammed , Miller, Jake A. , Chawareb, Elia Abou , Amini, Erfan , Hatzichristodoulou, Georgios , Lentz, A, Osmonov, D, Suarez‐Sarmiento, Alfredo, Azad, Babak Kazemzadeh , Jenkins, Lawrence C. , Jones, James M. , collaborators, on behalf of the PUMP (Prosthetic Urology Multi-institutional Partnership), Barham, DW

Mayo Clinic

The Journal of Sexual Medicine | October 25, 2025 | Volume: 21 | Issue: Supplement_6 | Pages: No page available

10.1093/jsxmed/qdae161.010 Get It

Abstract Introduction Obesity, defined as an elevated Body Mass Index (BMI) >30, is a prevalent public health concern with far-reaching implications for various medical procedures and outcomes. In the context of inflatable penile prosthesis placement (IPP), where patient well-being and surgical success are of paramount importance, the impact of obesity on postoperative and intraoperative complications warrants thorough investigation. Objective Our study aimed to investigate the impact of BMI on both postoperative and intraoperative complications in an international, multi-institutional cohort of patients who underwent IPP placement. Methods We performed a retrospective chart review of 4398 cases. These cases were divided into two distinct groups based on BMI: less than 30 (n = 2260) and greater than or equal to 30 (n = 2138). The study assessed various surgical factors as well as complications, including overall complications, corporal scarring, incontinence, intraoperative complications, proximal perforation, distal perforation, proximal crossover, distal crossover, and urethral injury. Results Our analysis revealed that there were no statistically significant differences in intraoperative or postoperative complications between the two BMI categories. Notably, proximal corporal measurement was significantly higher for >30 BMI group (9.55 +/−2.18) compared to <30 BMI group (9.14 +/−2.19), (p = < 0.001). The incidence rates for overall complications (30.2% vs. 28.7%; p = 0.164), corporal scarring (18.2% vs. 16.7%; p = 0.36), incontinence (3.53% vs. 3.13%; p = 0.076), intraoperative complications (1.94% vs. 1.68%; p = 0.253), and specific complications all exhibited no significant differences. Similarly, post-operative complications, including both non- infectious (6.99% vs. 6.22%; p = 0.215) and infectious (2.61% vs. 1.87%; p = 0.165) complications, did not significantly vary between BMI categories. Conclusions Our findings indicate that BMI does not exert a statistically significant influence on postoperative and intraoperative complications in the context of high-volume prosthetic urology. In the absence of any other differences between patients of differing BMIs, surgeons may need to be mindful of pump tubing length concerns in obese patients. Disclosure Any of the authors act as a consultant, employee or shareholder of an industry for: Coloplast, Clarus Therapeutics, Antares Pharma, Acerus.
CD1d+ Goblet Cells Expand Colon-Resident Immature, Intermediate and Differentiated iNKT Cells to Limit Colitis
Newberry, Rodney D. , John, Vini , Barrios, Bibiana E., Wang, Jacqueline D. , Udayan, Sreeram , Floyd, Alexandria N., Joyce, Elisabeth L, Sundas, Shushma, McDonald, Keely G. , Blumberg, Richard S. , Hsieh, Chyi, Rusconi, Brigida , Wang, Jacqueline D , Udayan, Sreeram , Mavers, Melissa , Blumberg, Richard S , Rusconi, Brigida , Newberry, Rodney D , Knoop, Kathryn A. , Schill, Ellen Merrick , Jayasinghe, Reyka G.

Mayo Clinic

No container title available | September 25, 2025 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.21203/rs.3.rs-7603392/v1 | PMID 41041542 Get It

Abstract Invariant Natural Killer T (iNKT) cells recognize glycolipid antigens presented on CD1d and rapidily respond to direct immune responses. iNKT cells develop in the thymus and migrate to peripheral tissues in what has been presumed to be differentiated/committed states. Accordingly, colonic iNKT cells are established in early life, considered to remain ‘fixed’ post-weaning, and determine life-long colitis susceptibility. Using single cell RNA sequencing (scRNA-seq), we demonstrate that humans and mice contain colonic iNKT populations transcriptionally resembling immature and intermediate thymic iNKT precursors. Contrary to prevailing paradigms, we demonstrate colonic iNKT cell populations expand in adult mice when CD1d expressing colonic goblet cells form goblet cell-associated antigen passages. Expansion preferentially affected intermediate iNKT cells, was durable, and protective in a colitis model. These studies reveal that the adult colon harbors iNKT cells with retained plasticity and uncover a novel role for goblet cells as unconventional antigen presenting cells regulating this axis.